Wei-Yu Chen

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2024
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT.

Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh

|Nov 24, 2021
PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer.

Yu-Ching Wen, Chien-Liang Liu, Hsiu-Lien Yeh

|Nov 20, 2021
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen, Yen-Nien Liu, Hsiu-Lien Yeh

|Sep 23, 2020
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.

Shian-Ren Lin, Yu-Ching Wen, Hsiu-Lien Yeh

|Aug 17, 2017
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.

Wei-Yu Chen, Yuan-Chin Tsai, Hsiu-Lien Yeh

Pageof 1

Frequent Collaborators

6 joint publications

Yu-Ching Wen

3 joint publications

Hsiu-Lien Yeh

2 joint publications

Michael Hsiao

1 joint publications

Florent Suau